Arbutus Biopharma's total assets for Q4 2024 were $131.71M, a decrease of -6.22% from the previous quarter. ABUS total liabilities were $34.34M for the fiscal quarter, a 2.35% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.